CALA News

11 IPOs priced during the week of September 29, but only 3 had any meaningful gains, including two tech deals and American Addiction Centers, a network of substance abuse treatment centers. The group raised $2.4 billion; 25% less than expected after frac sand maker Fairmount Santrol cut its deal size 60% to just $400 million. Fairmount was one of five offerings with private equity...read more

Calithera Biosciences, an early-stage biotech developing a drug platform that inhibits tumor metabolism, raised $80 million by offering 8 million shares (upsized from 6 million) at $10, below the range of $13 to $15. Calithera Biosciences plans to list on the NASDAQ under the symbol CALA. Calithera Biosciences initially filed confidentially on 7/25/2014. Citi and Leerink Partners...read more

Heightened IPO activity continues with 11 IPOs set to raise $3.2 billion this week, following the nine companies that went public last week. The week ahead should see five private equity-backed IPOs, including four LBOs and one...read more

Calithera Biosciences, a early-stage biotech developing a drug platform that inhibits tumor metabolism, announced terms for its IPO on Friday. The San Francisco, CA-based company plans to raise $84 million by offering 6 million shares at a price range of $13 to $15. Insiders intend to purchase $15 million in shares in the offering (18% of the deal). At the midpoint of the proposed...read more